© 2007 American Public Health Association DOI: 10.2105/AJPH.2005.082115
Tsung-Hsi Wang, Wei-Hui Chou, Wen-Yi Shih, and Hsu-Sung Kuo are with the Taiwan Centers for Disease Control, Taipei, Taiwan. Chao Agnes Hsiung is with Taiwan National Health Research Institute, Miaoli, Taiwan. Kuo-Chen Wei is with Chang Gung Memorial Hospital, Taoyuan, Taiwan. Susan A. Maloney, Rachel Barwick Eidex, and Drew L. Posey are with the Centers for Disease Control and Prevention, Atlanta, Ga. Correspondence: Correspondence should be sent to Hsu-Sung Kuo, Taiwan Centers for Disease Control, Department of Health, No. 6, Linshen South Rd, Taipei, Taiwan (e-mail: kuohsusung{at}yahoo.com).
Taiwan used quarantine as 1 of numerous interventions implemented to control the outbreak of severe acute respiratory syndrome in 2003. From March 18 to July 31, 2003, 147 526 persons were placed under quarantine. Quarantining only persons with known exposure to people infected with severe acute respiratory syndrome could have reduced the number of persons quarantined by approximately 64%. Focusing quarantine efforts on persons with known or suspected exposure can greatly decrease the number of persons placed under quarantine, without substantially compromising its yield and effectiveness.
Early in the 2003 global outbreak of severe acute respiratory syndrome (SARS), modes of transmission of SARS were unclear, and health officials used quarantine as 1 measure to contain this highly contagious emerging disease.1 Broad quarantine measures, which included both people who had been in contact with others reported to be infected with SARS and travelers from SARS-affected areas, were implemented in Taiwan. To guide planning and resource allocation for future response strategies, we identified risk factors for development of SARS among quarantined persons in Taiwan.
Two types of quarantine were implemented during the SARS outbreak in Taiwan: level A and level B quarantine. Level A quarantine was designed for persons who had known and, at times, had close exposure to persons infected with SARS in health care facilities and other community and domestic areas. Level B quarantine was designed for travelers who sat on the same flight within 3 rows of a person infected with SARS or were returning from World Health Organization–designated SARS-affected areas (whether or not they were on the same airplane as a person infected with SARS; Table 1
From March 18 to July 31, 2003, 52 255 persons were placed under level A quarantine. Of these, 102 (0.2%) persons developed suspect, probable, or laboratory-confirmed SARS. Persons at highest risk for the development of SARS were health care workers who had unprotected exposure to a patient with SARS (0.82%), patients from the same ward or nurse unit with SARS patients (0.48%), family members or relatives of a SARS patient (0.32%), and other nosocomial SARS exposures (0.25%; Table 1
During the same time period, 95 271 persons were placed under level B quarantine. Of these, 56 (0.06%) persons developed suspect, probable, or laboratory-confirmed SARS. Persons at highest risk for the development of SARS were those sitting within 3 rows of a SARS patient (0.25%; Table 1
Logistic regression was used to calculate risk factors for the development of SARS. Advanced age (> 60 years) was identified as a risk factor for SARS in both level A and level B quarantine (Table 2
During the SARS pandemic of 2003, quarantine was used as a public health tool to contain the transmission of SARS in Taiwan, Canada, Singapore, Hong Kong, and Mainland China.1,3–9 The types and intensity of quarantine measures implemented differed; evaluating the yield of quarantine measures can be useful for directing quarantine efforts in the future. During the outbreak in Taiwan, 147526 persons were placed under quarantine, and 158 (0.11%) persons developed suspect, probable, or laboratory-confirmed SARS. Persons under level A quarantine had a 3-times-higher rate of developing SARS than did persons under level B quarantine. Furthermore, persons initially placed in level B quarantine who were on the same flight within 3 rows of a person infected with SARS had rates of developing SARS similar to those in level A quarantine. Others have reported rates of developing SARS among quarantined persons that have been up to 10 times greater than those in this article.4,10,11 The reasons for this difference in rates are unclear but could be related to varying types and durations of exposure, susceptibility to SARS, or likelihood of developing symptoms after infection.10–13 Emerging disease outbreaks require rapid responses, and government officials are often called on to make decisions regarding the implementation of control measures, such as quarantine, on the basis of limited knowledge about disease transmission dynamics. During the SARS response in Taiwan, there was scant information available that could have been used to definitively stratify or categorize contacts and travelers to avoid the unnecessary quarantine of low-risk individuals. Our study found that the efficiency of SARS quarantine measures could have been improved by targeting quarantine efforts to persons with known or suspected exposure to SARS cases in hospitals, homes, communities, and airplanes. Restricting quarantine measures to only these persons could have reduced the number of persons quarantined by 64%, without compromising overall yield and efficiency. Similar findings have been reported from Beijing and Canada where transmission of SARS was limited to persons who had known exposure and close contact with SARS cases.4,7–9 These data can be used to inform future responses and allocation of scarce public health resources if SARS returns and additional cost–benefit analyses are warranted. In addition, these findings support pursuing modeling to determine the most effective intervention strategies for other potential infectious disease emergencies, including pandemic influenza.
We thank our infectious disease control colleagues, members of our local branches and particularly local public health workers in the frontline during SARS outbreak for their great contributions.
Human Participation Protection
Peer Reviewed
Contributors Accepted for publication May 3, 2006.
1. Twu SJ, Chen TJ, Chen CJ, et al. Control measures for severe acute respiratory syndrome (SARS) in Taiwan. Emerg Infect Dis 2003;9:718–720.[Web of Science][Medline] 2. World Health Organization. Case definitions for surveillance of severe acute respiratory syndrome (SARS). Available at: http://www.who.int/csr/sars/casedefinition/en. Accessed August 15, 2003. 3. Centers for Disease Control and Prevention. Use of quarantine to prevent transmission of severe acute respiratory syndrome-Taiwan, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:680–683.[Medline] 4. Centers for Disease Control and Prevention. Efficiency of quarantine during an epidemic of severe acute respiratory syndrome-Beijing, China, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:1037–1040.[Medline] 5. Centers for Disease Control and Prevention. Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:405–411.[Medline] 6. Centers for Disease Control and Prevention. Severe acute respiratory syndrome (SARS) and coronavirus testing-United States, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:297–302.[Medline] 7. Poutanen SM, Low DE, Henry B, et al. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348:1995–2005. 8. Centers for Disease Control and Prevention. Update. Severe acute respiratory syndrome-Toronto, Canada, 2003. MMWR Morb Mortal Wkly Rep. 2003;52: 547–550.[Medline] 9. Yu ITS, Li Y, Wong TW, et al. Evidence of airborne transmission of the severe acute respiratory syndrome virus. N Engl J Med. 2004;350:1731–1739. 10. Pang X, Zhu Z, Xu F, et al. Evaluation of control measures implemented in the severe acute respiratory syndrome outbreak in Beijing, 2003. JAMA. 2003; 290:3215–3221. 11. Li Q, Zeng G, Ou J, et al. Epidemiological study of transmission chain of a severe acute respiratory syndrome outbreak. Natl Med J China. 2003;83: 906–909. 12. Centers for Disease Control and Prevention. Severe acute respiratory syndrome-Taiwan, 2003. MMWR Morb Mortal Wkly Rep. 2003;52:461–466.[Medline] 13. Wu HS, Chiu SC, Lin CH, et al. The PCR and serological testing of probable SARS cases in Taiwan. In: Memoir of Severe Acute Respiratory Syndrome Control in Taiwan, Taiwan: Centers for Disease Control; 2003: 27–31. This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||